Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively). SU4312 (SU 4312) unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 8,000 | |||
2 mg | 在庫あり | ¥ 11,000 | |||
5 mg | 在庫あり | ¥ 18,500 | |||
10 mg | 在庫あり | ¥ 32,000 | |||
25 mg | 在庫あり | ¥ 59,500 | |||
50 mg | 在庫あり | ¥ 92,500 |
説明 | SU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively). SU4312 (SU 4312) unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS. |
ターゲット&IC50 | VEGFR:0.8 μM, PDGFR:19.4 μM |
別名 | SU 4312, NSC 86429 |
分子量 | 264.32 |
分子式 | C17H16N2O |
CAS No. | 5812-07-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (208.07 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SU4312 5812-07-7 Angiogenesis Tyrosine Kinase/Adaptors PDGFR VEGFR NSC86429 Inhibitor SU 4312 NSC 86429 inhibit Vascular endothelial growth factor receptor NSC-86429 Platelet-derived growth factor receptor SU-4312 inhibitor